What we found on the web about Sanofi Aventis
Sanofi-Aventis - Wikipedia, the free encyclopedia
Sanofi-Aventis (Euronext: SAN, NYSE: SNY), headquartered in Paris, France, is a multinational pharmaceutical company, the world's fourth-largest by prescription sales.
Aventis - Wikipedia, the free encyclopedia
It become part of Sanofi-Aventis in 2004. The name Aventis is derived from the Roman Goddess Minerva, the virgin goddess of warriors, poetry, medicine, wisdom, and music.
Contact information for sanofi-aventis with information about medical ...
Sanofi-aventis company contact information for customers, job seekers, patients, health care professionals, stakeholders, investors and shareholders with questions about company ...
Sanofi-aventis ANZ
sanofi-aventis pharmaceutical research, development, careers and product information for pharmaceuticals, cardiovascular diseases, bone diseases, oncology, central nervous system ...
Sanofi-aventis - Kosmix : Reference, Videos, Images, News, Shopping ...
Stock Market News: Google, Apple, Pfizer, Sanofi-Aventis | Daily ..... 4 days ago. Pfizer [[PFE]] Lyrica anti-anxiety drug was rejected by the FDA as data showed the drug was ...
Sanofi-aventis to acquire BiPar Sciences, a US biopharmaceutical ...
Sanofi-aventis www.sanofi-aventis.com Media Relations: Tél. : (+) 33 1 53 77 44 50 - E-mail : MR@sanofi-aventis.com Investor Relations : Tél. : (+) 33 1 53 77 45 45 - E-mail : IR ...
Sanofi-Aventis - SourceWatch
SourceWatch needs your financial support to survive and thrive. If you've found this information on the people, organizations, and issues shaping the public agenda helpful, please ...
Entry added by Creative Administrator
Creative Administrator also edited:
Here is what users have to say about Sanofi Aventis

Sanofi-Aventis ( , NYSE: SNY), headquartered in Paris, France, is a multinational pharmaceutical company, the world's fourth-largest by prescription sales. Sanofi-Aventis engages in the research and development, manufacturing and marketing of pharmaceutical products for sale principally in the prescription market, but the firm also develops over-the-counter medication. Sanofi-Aventis covers 7 major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis and vaccines (it is the world's largest producer of the latter through its subsidiary Sanofi Pasteur). The company is a full member of the European Federation of Pharmaceutical Industries and Associations (EFPIA).

Welcome to CWAnswers

CWAnswers is your guide to the sprawling world wide web. The directory aims to provide a useful guide made by users. You can share your knowledge as well - simply register and edit your first entry. For questions just contact the team at support - at - cwanswers.com.

Weblinks

Top 10

Things you find nowhere else.

Comments

You must be logged in to post a comment.

No comments yet on this topic. Be the first one!
These recent articles mention Sanofi Aventis
Chattem chiefs get paid to stay
Chattanooga Times Free Press
Chattem's four top executives could receive retention bonuses totaling more than $16 million over up to five years as a result of its deal with Sanofi-Aventis, documents show. Also, if Chattem finds a superior partner before the deal with t...
France Cancels 50 Million Flu Shot Orders
Post Chronicle
France ordered the vaccinations from Sanofi-Pasteur, a unit of Sanofi-Aventis, GlaxoSmithKline, Novartis and Baxter International. The government estimated 94 million individual shots were needed, thinking that everyone would need two jabs ...
France cuts swine flu vaccine order from Novartis
Reuters
The French government said on Monday it aimed to cancel 50 million of the 94 million doses ordered from Sanofi-Aventis, GlaxoSmithKline, Novartis and Baxter International because of over-supply, adding it was discussing the cuts with suppli...
European stocks flat; banks up, pharmas down
The Guardian
France had ordered the shots from Sanofi-Pasteur, a unit of Sanofi-Aventis, GlaxoSmithKline, Novartis and Baxter International. But a Sanofi Pasteur spokesman said the impact on sales would be minimal. "We don't expect this change in the Fr...
France wants to sell millions of surplus flu shots
Reuters
France bought vaccinations from Sanofi-Pasteur, a unit of Sanofi-Aventis, GlaxoSmithKline, Novartis and Baxter International). Some five million people in France have so far been vaccinated against H1N1, health officials say. The flu virus ...
Sanofi-Aventis Commits Support to DiabetesSisters
dBusinessNews.com
RALEIGH – DiabetesSisters, a North Carolina-based nonprofit organization, announced today that Sanofi-aventis has pledged $20,000 the organization’s 2010 efforts to improve the health and quality of life of women with diabetes. “To have the...
Glaxo Ready to Renegotiate French Vaccine Order, Challenges Says
Bloomberg
Sanofi Pasteur, a unit of French drugmaker Sanofi Aventis SA, has also said it would “examine” any request to renegotiate its own contract with the state to supply 28 million doses of the vaccine, according to Challenges. France is selling ...
What to expect for Sanofi-Aventis approach on novel mAb against ...
Gerson Lehrman Group
What to expect for Sanofi-aventis exclusive global licensing agreement with The Rockefeller University, in particular with Dr. Jeffrey Ravetch, whose expertise is in the engineering of mAb Fc region and effector functions? The agreement is ...
Novartis Buys Alcon Majority for $28.1 Billion
ABC News
Drugmakers like Novartis, GlaxoSmithKline and Sanofi-Aventis are pushing into areas like consumer healthcare and generics as they face the biggest loss of patent protection in history. Nestle said in a separate statement it would launch a n...
Obama to speak on economy, announce more spending for green jobs as ...
Minneapolis Star Tribune
NM utility to refile renewable energy plan Source: NBC weighing Leno return to late-night UPS cutting 1,800 jobs in US, raising outlook Economy loses 85K jobs, unemployment rate steady Sanofi-Aventis appoints new VP, consumer health WASHING...
Associates involved in service of their choice
Northwest Explorer
At Sanofi-aventis' Tucson Research Center, community outreach is simply "us being part of the community," according to chemist, senior research investigator and Oro Valley resident John Okonya. Through community service, the company and its...